disease | mecfa

MECFA Blog

World-first clinical trial raises hopes of new drug for chronic lung disease

CHRONIC lung disease sufferers could be aided by a new drug which helps reduce the need for antibiotics, according to a clinical trial....

Case Report Cites IDPN as Nutritional Tool in CF Patients with Kidney Disease

Delivering nutrients through dialysis could help people with co-occurring cystic fibrosis (CF) and kidney disease meet their nutritional...

Disease-causing protein in cystic fibrosis has ancient roots in sea lamprey

The oldest known ortholog of the ion channel that is defective in patients with cystic fibrosis arose approximately 450 million years ago...

Human pancreas on a chip can reveal more about disease

A researcher holds a dual-chamber chip that scientists used to bioengineer human pancreatic tissues to study the cause of Cystic...

Ultrasound Can Help Detect Liver Disease in Kids with CF, Study Says

Ultrasound imaging can be a reliable diagnostic tool for early detection of liver disease in children with cystic fibrosis (CF), a study...

Lovelace Biomedical Talks About Developing Novel Therapies for Cystic Fibrosis Month

May is Cystic Fibrosis (CF) month. Lovelace has been working in respiratory research for over 70 years, and has been using gene therapy...

New Gene Therapy Strategy May Reverse Effects of Disease-related Mutations, Study Shows

A new strategy to genetically prevent disease-related mutations from occurring shows the potential to treat several genetic diseases,...

Link Found Between P. aeruginosa Infection and Disease Severity in CF Patients, Study Reports

Patients with cystic fibrosis (CF) whose lungs have never been colonized by the Pseudomonas aeruginosa bacterium have a milder form of...

The Diverse Spectrum of Health Across the CF Community

If you’ve ever met more than one person with cystic fibrosis, it’s likely they had very different experiences than you. First, their...

People with Rare Diseases Are Humans, Not Commodities

If you keep up with CF research, you may have seen the news about Phase 3 of the triple combination Vertex therapies. In these results,...

Disease Duration, Flare-ups Affect Mental Health of Non-CF Bronchiectasis Patients, Study Finds

VERTEX’S CF BLOCKBUSTER TRIKAFTA EFFECTIVE IN KIDS 6 TO 11 YEARS OF AGE

A case for improved carrier screening

Vertex to Seek Expanded FDA Approval for Trikafta After Positive Child Safety Data

Vertex’s Kaftrio approved for use in Europe and made accessible on the NHS

Age May Affect Outcomes in Lung Transplant Recipients With Cystic Fibrosis

CFF Funding Will Further ContraFect’s Research Into Alternative for Antibiotics

The search for molecular glue in targeted disease control

Vest Therapy Lowers Risk of Hospitalization in Non-CF Bronchiectasis, Study Says

Harvard is working with Boston hospitals to test existing cystic fibrosis drug to help coronavirus p